Search Results 541-550 of 16336 for first aid index

  1. Hiccups - Diagnosis and treatment - Mayo Clinic

    During the physical exam, your health care provider may perform a neurological exam to check your: Balance and coordination. Muscle strength and tone. Reflexes.

  2. Electromyography Clinical Trials - Mayo Clinic Research

    The first purpose is to investigate the effect of ... The current study is a continuation of the project: “Bispectral Index: A Comparison of Bifrontal Montage ...

  3. Experts in diagnosis - Mayo Clinic

    Getting the diagnosis right the first time means you receive the care you need when you need it.

  4. Dose-Escalation Study of cevostamab (BFCR4350A) in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM) - Mayo Clinic

    Participation eligibility · Platelet count ≥ 50,000/mm^3 without transfusion within 7 days prior to first dose; · ANC ≥ 1000/mm^3; · Total hemoglobin ≥ 8 g/dL; ...

  5. Persistent post-concussive symptoms (Post-concussion syndrome) - Diagnosis and treatment - Mayo Clinic

    You first may see a member of your healthcare team, who makes the initial ... https://www.cdc.gov/traumatic-brain-injury/prevention/index.html.

  6. MCAD deficiency - Diagnosis and treatment - Mayo Clinic

    For example, during the first 4 months of life, well infants' fasting time ... https://www.hrsa.gov/advisory-committees/heritable-disorders/rusp/index.html.

  7. Valerian: A safe and effective herbal sleep aid? - Mayo Clinic

    I read that the herbal supplement valerian can help you fall asleep if you have insomnia. Is valerian safe, and does it actually work? · Medication may not be ...

  8. CON-20155333-Care at MC-Treatment of adrenal disease at Mayo Clinic

    McKenzie: There's a lot of reasons to come to Mayo Clinic for evaluation of adrenal tumors. So first and foremost is our multi-disciplinary approach. We have a ...

  9. A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma - Mayo Clinic

    Screening of subjects to determine eligibility for the study will be performed within 21 days of the first planned dose of tazemetostat. ... first dose of ...

  10. Pembrolizumab Plus Epacadostat Alone or With Platinum-based Chemotherapy Versus Pembrolizumab Plus Platinum-based Chemotherapy Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-715-02/ECHO-306) - Mayo Clinic

    ... first-line therapy in participants with metastatic non-small cell lung cancer (NSCLC). Participation eligibility. Participant eligibility includes age ...